The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
ARK Genomic Revolution ETF ARKG
Morningstar’s Analysis ARKG
Will ARKG outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Twist Bioscience Corp | 8.19 | 119.7 Mil | Healthcare |
CRISPR Therapeutics AG | 6.57 | 96.0 Mil | Healthcare |
CareDx Inc | 6.15 | 89.8 Mil | Healthcare |
Recursion Pharmaceuticals Inc Class A | 6.10 | 89.1 Mil | Healthcare |
Intellia Therapeutics Inc | 4.34 | 63.4 Mil | Healthcare |
Schrodinger Inc Ordinary Shares | 3.82 | 55.7 Mil | Healthcare |
Moderna Inc | 3.69 | 53.9 Mil | Healthcare |
Ionis Pharmaceuticals Inc | 3.63 | 53.1 Mil | Healthcare |
Arcturus Therapeutics Holdings Inc | 3.60 | 52.6 Mil | Healthcare |
Beam Therapeutics Inc | 3.58 | 52.3 Mil | Healthcare |